Amarin Corp PLC (AMRN)
0.551
+0.03
(+4.97%)
USD |
NASDAQ |
Nov 22, 14:53
Amarin Shareholders Equity (Quarterly): 531.38M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 531.38M |
June 30, 2024 | 551.88M |
March 31, 2024 | 545.94M |
December 31, 2023 | 552.10M |
September 30, 2023 | 553.15M |
June 30, 2023 | 569.13M |
March 31, 2023 | 584.79M |
December 31, 2022 | 595.33M |
September 30, 2022 | 587.83M |
June 30, 2022 | 580.04M |
March 31, 2022 | 641.11M |
December 31, 2021 | 667.10M |
September 30, 2021 | 642.50M |
June 30, 2021 | 645.32M |
March 31, 2021 | 634.61M |
December 31, 2020 | 627.50M |
September 30, 2020 | 607.26M |
June 30, 2020 | 602.76M |
March 31, 2020 | 585.78M |
December 31, 2019 | 608.26M |
September 30, 2019 | 595.90M |
June 30, 2019 | 149.09M |
March 31, 2019 | 140.87M |
December 31, 2018 | 152.33M |
September 30, 2018 | -52.83M |
Date | Value |
---|---|
June 30, 2018 | -46.69M |
March 31, 2018 | -16.66M |
December 31, 2017 | -65.10M |
September 30, 2017 | -46.11M |
June 30, 2017 | -38.76M |
March 31, 2017 | -28.77M |
December 31, 2016 | -9.058M |
September 30, 2016 | 15.18M |
June 30, 2016 | -164.42M |
March 31, 2016 | -156.14M |
December 31, 2015 | -127.55M |
September 30, 2015 | -111.09M |
June 30, 2015 | -91.35M |
March 31, 2015 | -61.82M |
December 31, 2014 | -88.45M |
September 30, 2014 | -69.24M |
June 30, 2014 | -49.98M |
March 31, 2014 | -57.59M |
December 31, 2013 | -33.86M |
September 30, 2013 | -17.70M |
June 30, 2013 | -94.33M |
March 31, 2013 | -60.09M |
December 31, 2012 | -3.997M |
September 30, 2012 | 0.038M |
June 30, 2012 | 5.32M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
531.38M
Minimum
Sep 2024
667.10M
Maximum
Dec 2021
595.69M
Average
591.58M
Median
Shareholders Equity (Quarterly) Benchmarks
Trinity Biotech PLC | -26.34M |
Adaptimmune Therapeutics PLC | 79.99M |
Akari Therapeutics PLC | -6.694M |
NuCana PLC | 4.806M |
TC BioPharm (Holdings) PLC | 1.364M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 750.62M |
Total Liabilities (Quarterly) | 219.24M |
Current Ratio | 3.226 |